background
extracellular
domain
cytokin
receptor
releas
inflamm
littl
known
shed
tolllik
receptor
tlr
whether
use
diagnost
biomark
method
releas
studi
invitro
stimul
well
invivo
experiment
human
endotoxemia
n
ngkg
lp
plasma
patient
infect
infecti
mononucleosi
measl
respiratori
tract
infect
bacteri
sepsi
candidemia
noninfecti
inflamm
crohn
diseas
gout
rheumatoid
arthriti
autoinflammatori
syndrom
pancreat
use
cstatist
valu
level
discrimin
infect
noninfecti
inflammatori
diseas
well
viral
bacteri
infect
analyz
result
invitro
peripher
blood
mononuclear
cell
releas
exposur
microbi
ligand
experiment
human
endotoxemia
plasma
concentr
peak
hour
hour
correl
cytokin
correl
posit
r
p
r
p
r
p
neg
r
p
respect
similar
area
roc
curv
auc
differenti
infecti
noninfecti
inflamm
compar
crp
ci
versu
ci
p
lower
auc
ci
p
crp
differenti
bacteri
infect
better
viral
infect
auc
ci
versu
ci
ci
respect
p
conclus
stlr
releas
circul
suggest
possibl
use
stlr
diagnost
tool
inflammatori
condit
figur
roc
curv
crp
comparison
patient
infect
noninfecti
inflamm
left
panel
patient
bacteri
viral
infect
right
panel
auc
shown
bracket
pvalu
indic
comparison
auc
crp
ten
oever
et
al
bmc
immunolog
tolllik
receptor
tlr
germlineencod
receptor
recogn
microbi
structur
call
pathogenassoci
molecular
pattern
pamp
either
alon
combin
coreceptor
besid
regul
innat
adapt
immun
respons
tlr
signal
play
import
role
pathogenesi
sever
inflammatori
diseas
tight
regul
crucial
order
prevent
hyperinflamm
immun
signal
regul
multipl
level
releas
extracellular
domain
immun
receptor
cytokin
receptor
repres
import
regulatori
mechan
similar
neg
regul
account
modul
tlr
function
solubl
form
recent
describ
releas
solubl
protein
increas
upon
cell
activ
exert
inhibitori
activ
tlr
signal
solubl
form
tlr
detect
pleural
fluid
amniot
fluid
saliva
breast
milk
plasma
time
knowledg
etiolog
inflammatori
condit
crucial
facilit
appropri
treatment
also
unnecessari
intervent
may
avoid
light
critic
shortag
new
antibiot
reduct
antibiot
prescript
warrant
concept
measur
solubl
pattern
recognit
receptor
prr
diagnosi
infect
previous
propos
howev
analysi
solubl
tlr
till
use
diagnost
workup
pleural
effus
intraamniot
infect
aim
present
studi
gain
insight
releas
invitro
investig
kinet
monocyt
express
plasma
level
solubl
counterpart
experiment
endotoxemia
intraven
lp
administr
healthi
volunt
furthermor
hypothes
solubl
form
receptor
play
pivot
role
pathogen
recognit
cell
innat
immun
system
differenti
releas
variou
inflammatori
diseas
higher
level
inflammatori
condit
infecti
origin
evalu
abil
level
discrimin
infecti
noninfecti
inflammatori
patholog
peripher
blood
mononuclear
cell
pbmc
isol
buffi
coat
healthi
individu
inform
consent
briefli
pbmc
isol
densiti
gradient
centrifug
use
ficollpaqu
plu
ge
healthcar
zeist
netherland
collect
white
interphas
cell
wash
twice
cold
pb
concentr
adjust
cellsml
supplement
mm
lglutamin
mm
pyruv
gentamicin
gibco
invitrogen
carlsbad
ca
mononuclear
cell
volum
ad
roundbottom
plate
greiner
nurnberg
germani
incub
either
cultur
medium
neg
control
lp
e
coli
sigmaaldrich
st
loui
mo
heatkil
e
coli
atcc
microorganismsml
hour
incub
supernat
store
measur
studi
part
larger
endotoxin
trial
regist
clinicaltrialsgov
registri
number
approv
local
ethic
committe
radboud
univers
medic
center
healthi
male
volunt
includ
present
studi
provid
written
inform
consent
briefli
subject
prehydr
h
lp
administr
infus
l
salin
solut
follow
mlh
start
time
lp
administr
h
afterward
mlh
end
experi
us
refer
escherichia
coli
endotoxin
lp
deriv
e
coli
clinic
center
refer
endotoxin
nation
institut
health
bethesda
md
administ
intraven
bolu
ngkg
edta
anticoagul
blood
collect
arteri
line
order
determin
express
blood
collect
edtacontain
vacutain
follow
directli
conjug
mous
antihuman
antibodi
use
pe
mous
tlr
clone
ebiosci
san
diego
ca
mous
clone
ebiosci
san
diego
ca
ecd
mous
clone
immunotech
beckman
coulter
marseil
franc
isotyp
fluorochrom
match
control
beckman
coulter
use
cell
buffer
solut
use
contain
bovin
serum
albumin
phosphat
buffer
salin
sodium
azid
rabbit
serum
invitrogen
carlsbad
ca
block
dilut
cell
buffer
solut
red
blood
cell
lysi
perform
use
ammonium
chlorid
freshli
prepar
ml
blood
mix
ml
lyse
solut
left
room
temperatur
minut
centrifug
minut
g
supernat
discard
cell
pellet
resuspend
ml
pb
centrifug
wash
step
cell
pellet
resuspend
ml
cell
buffer
solut
ml
cell
suspens
mix
ml
rabbit
serum
left
room
temperatur
min
subsequ
cell
incub
appropri
antibodi
concentr
mixtur
min
dark
room
temperatur
wash
sampl
resuspend
ml
cell
buffer
solut
analyz
beckman
coulter
flow
cytomet
beckman
coulter
miami
fl
monocyt
gate
side
scatter
vs
plot
fluorochrom
match
isotyp
control
nonstain
sampl
well
cell
incub
secondari
antibodi
use
set
photo
multipli
detector
express
analyz
within
monocyt
plasma
concentr
measur
healthi
control
two
group
patient
compar
use
inflammatori
biomark
creactiv
protein
crp
edta
anticoagul
blood
variou
group
patient
prospect
collect
plan
laboratori
blood
assess
clinic
purpos
avail
previou
clinic
studi
indic
plasma
obtain
centrifug
minut
g
studi
carri
netherland
accord
applic
rule
concern
review
research
ethic
committe
inform
consent
inclus
exclus
criteria
inflammatori
disord
shown
tabl
tabl
show
demograph
characterist
healthi
control
patient
includ
first
group
consist
patient
infecti
diseas
plasma
obtain
hour
present
viral
lower
respiratori
tract
infect
lrti
n
tabl
measl
n
infecti
mononucleosi
caus
either
epsteinbarr
viru
ebv
cytomegaloviru
cmv
infect
n
bacteri
viral
respiratori
coinfect
n
tabl
bacteri
sepsi
stratifi
sepsi
sever
sepsi
septic
shock
n
candidemia
n
second
group
compris
patient
noninfecti
inflamm
crohn
diseas
n
gout
n
autoinflammatori
syndrom
n
rheumatoid
arthriti
n
pancreat
n
patient
autoinflammatori
syndrom
consist
mainli
patient
wellknown
genet
confirm
autoinflammatori
diseas
like
hyperimmunoglobulind
syndrom
famili
mediterranean
fever
mucklewel
syndrom
tumor
necrosi
factor
associ
syndrom
trap
pancreat
biliari
origin
none
develop
necrosi
neg
blood
cultur
sampl
taken
hour
present
except
crohn
diseas
reumatoid
arthriti
taken
exacerb
diseas
tabl
diseas
activ
rheumatoid
arthriti
measur
diseas
activ
score
da
joint
definit
activ
rheumatoid
arthriti
mean
rang
patient
score
indic
high
diseas
activ
cytokin
measur
concentr
measur
commerci
elisa
kit
uscn
life
scienc
inc
wuhan
china
lower
limit
detect
ngml
ngml
respect
commerci
elisa
sanquin
amsterdam
netherland
minim
detect
level
pgml
use
determin
interleukin
il
concentr
supernat
tumor
necrosi
factor
tnf
concentr
plasma
determin
use
luminex
assay
bioplex
cytokin
assay
biorad
hercul
ca
sensit
pgml
pgml
pgml
pgml
respect
crp
concentr
measur
commerci
elisa
lower
detect
limit
mgl
ibl
intern
hamburg
germani
sampl
dilut
appropri
cytokin
stlr
concentr
invitro
endotoxemia
experi
express
mean
sem
assess
correl
spearman
correl
coeffici
calcul
mannwhitney
utest
use
comparison
two
group
biomark
studi
addit
correct
potenti
influenc
age
sex
biomark
concentr
perform
multipl
linear
regress
analysi
forc
entri
method
biomark
interest
depend
variabl
age
sex
assign
group
infectionno
infect
bacterialvir
infect
independ
variabl
receiv
oper
characterist
roc
curv
statist
appli
calcul
sensit
specif
order
determin
diagnost
accuraci
combin
biomark
logist
regress
analysi
use
estim
predict
probabl
subsequ
use
gener
roc
curv
method
describ
delong
use
compar
area
roc
curv
auc
test
twosid
p
consid
statist
signific
data
analyz
use
graph
pad
prism
graphpad
softwar
la
jolla
ca
medcalc
version
medcalc
softwar
mariakerk
belgium
invitro
releas
solubl
tlr
human
pbmc
detect
limit
ngml
respect
supernat
unstimul
pbmc
stimul
lp
heatkil
e
coli
signific
amount
releas
pbmc
supernat
although
shed
stlr
confin
stimul
correspond
cell
surfac
receptor
figur
releas
human
endotoxemia
plasma
concentr
display
distinct
pattern
lp
infus
figur
lp
administr
level
undetect
low
volunt
concentr
increas
lp
infus
reach
peak
concentr
hour
lp
infus
peak
hour
mean
peak
valu
sem
ngml
ngml
pgml
pgml
pgml
pgml
respect
auc
show
correl
auc
r
p
r
p
r
p
r
p
r
p
howev
show
strong
posit
correl
r
p
r
p
show
trend
toward
posit
correl
r
p
neg
r
p
respect
cellsurfac
express
monocyt
vari
extens
among
subject
without
clear
pattern
correl
plasma
level
figur
figur
show
circul
concentr
crp
variou
infecti
noninfect
inflammatori
diseas
patient
healthi
volunt
includ
determin
crp
sampl
patient
healthi
volunt
analyz
crp
circul
concentr
significantli
higher
patient
infect
compar
patient
noninfecti
inflamm
figur
group
b
correct
age
sex
presenc
infect
still
posit
associ
crp
unstandard
coeffici
ci
p
ci
p
ci
p
respect
age
sex
also
posit
associ
three
biomark
concentr
furthermor
compar
patient
suffer
viral
infect
patient
bacteri
infect
display
higher
concentr
crp
figur
group
c
multivari
analysi
correct
age
sex
show
three
biomark
independ
associ
presenc
bacteri
infect
unstandard
coeffici
crp
ci
p
ci
p
ci
p
respect
neither
sex
age
prove
influenc
concentr
crp
patient
bacteri
fungal
sepsi
presenc
malign
n
without
malign
n
associ
higher
concentr
crp
vs
mgl
p
vs
ngml
p
vs
ngml
p
although
reach
statist
signific
discrimin
valu
level
identifi
infecti
versu
noninfecti
inflamm
similar
compar
crp
auc
ci
ci
p
tabl
figur
perform
wors
auc
ci
p
compar
auc
crp
specif
circul
concentr
ngml
ngml
crp
mgl
sensit
respect
identifi
infecti
process
combin
biomark
show
improv
auc
tabl
crp
level
show
good
valu
discrimin
bacteri
viral
infect
auc
ci
level
display
significantli
lower
auc
compar
crp
ci
p
poor
discrimin
patient
bacteri
viral
infect
tabl
figur
panel
analysi
two
biomark
compar
perform
crp
alon
cutoff
valu
figur
releas
stimul
hour
peripher
blood
mononuclear
cell
either
medium
control
sever
microbi
stimuli
data
express
mean
sem
n
concentr
incub
medium
detect
limit
ten
oever
et
al
bmc
immunolog
discrimin
bacteri
infect
viral
infect
specif
crp
mgl
sensit
ngml
sensit
ngml
sensit
present
studi
demonstr
releas
invitro
invivo
challeng
microbi
ligand
lp
significantli
elev
plasma
concentr
stlr
present
circul
experiment
human
endotoxemia
high
circul
concentr
found
patient
infect
compar
patient
noninfecti
inflamm
well
patient
bacteri
infect
compar
viral
infect
howev
valu
addit
diagnost
biomark
low
new
marker
surpass
crp
accuraci
addit
releas
stimul
immun
cell
constitut
releas
stlr
demonstr
variou
biolog
fluid
saliva
breast
milk
amniot
fluid
plasma
repres
sever
polypeptid
found
other
although
concentr
low
avoid
harm
insuffici
inflammatori
respons
inhibit
activ
immun
system
need
properli
balanc
variou
neg
regul
tlr
describ
constitut
import
firstlin
neg
regulatori
mechan
either
interfer
trigger
membranebound
dimer
cell
surfac
compet
cellular
microbi
ligand
complex
form
probabl
block
interact
membranebound
ligand
rapid
elev
plasma
upon
lp
administr
similar
proinflammatori
cytokin
indic
feedback
mechan
rapidli
activ
consist
invitro
data
releas
stlr
circul
demonstr
immun
modul
mediat
tlr
limit
stimul
correspond
receptor
cell
membran
immun
cell
sinc
dampen
inflamm
disrupt
tlrmediat
proinflammatori
respons
might
possibl
counter
regulatori
mechan
mediat
stlr
extend
interfer
endogen
tlr
ligand
although
kinet
concentr
parallel
antiinflammatori
cytokin
quantit
appear
differenti
regul
plasma
level
show
correl
neg
correl
found
interestingli
invitro
releas
immun
cell
compar
invivo
concentr
differ
strongli
much
higher
concentr
circul
suggest
much
rapid
clearanc
circul
may
impli
antiinflammatori
mechan
regul
differ
level
potenti
complementari
strategi
reduc
inflamm
recent
year
import
role
tlr
signal
discov
oncogenesi
particularli
inflammationdriven
tumor
although
relationship
cellbound
releas
solubl
form
clearcut
observ
higher
concentr
small
group
patient
underli
malign
may
reflect
increas
express
seen
form
cancer
altern
splice
mrna
encod
solubl
form
expect
correl
membran
express
circul
contrari
result
posttransl
process
endocytosi
cell
surfac
receptor
follow
convers
intracellularli
previou
monocyt
stimul
experi
membranebound
correl
neg
supernat
observ
downregul
cell
surfac
tlr
express
monocyt
individu
endotoxemia
possibl
explan
lack
correl
monocyt
detect
low
number
hour
lp
inject
subpopul
may
well
differ
tlr
express
activ
monocyt
margin
timepoint
examin
express
tlr
monocyt
howev
circul
cell
subset
neutrophil
platelet
also
express
potenti
contribut
plasma
concentr
stlr
solubl
receptor
deriv
intracellular
pool
directli
cell
surfac
final
besid
shed
membran
bound
tlr
influenc
tlr
traffick
intracellular
compart
cell
membran
import
aspect
studi
possibl
use
solubl
tlr
diagnost
marker
rapid
reliabl
differenti
noninfecti
inflammatori
disord
infect
classif
infect
accord
microbiolog
etiolog
essenti
optim
treatment
condit
far
small
number
studi
publish
stlr
diagnost
biomark
studi
group
report
intrauterin
infect
pregnant
women
character
elev
level
amniot
fluid
support
concept
stlr
releas
infect
assess
valu
level
discrimin
sever
inflammatori
condit
elev
respons
inflammatori
insult
particularli
show
good
specif
discrimin
infect
noninfecti
inflammatori
condit
gout
crohn
diseas
rheumatoid
arthriti
autoinflammatori
syndrom
moreov
concentr
show
high
specif
discrimin
bacteri
viral
infect
use
high
cutoff
valu
sensit
low
mention
howev
overal
discrimin
valu
stlr
level
superior
crp
rel
small
group
patient
assess
studi
futur
larger
valid
studi
demonstr
overal
valu
level
diagnosi
infect
autoinflammatori
diseas
relat
classic
inflammatori
marker
furthermor
besid
stlr
solubl
pattern
recognit
receptor
solubl
mannos
receptor
shed
cell
stimul
also
interest
candid
new
potenti
specif
diagnost
biomark
studi
also
limit
firstli
includ
rel
limit
number
clinic
condit
possibl
extrapol
result
entir
panel
infecti
noninfecti
inflammatori
diseas
secondli
studi
group
inflammatori
condit
whole
rather
focus
correl
clinic
inform
outcom
present
studi
import
initi
proofofprincipl
report
role
broad
panel
human
infect
autoinflammatori
diseas
shed
confin
stimul
correspond
cell
surfac
receptor
broader
effect
upon
stimul
innat
immun
cell
pattern
recognit
receptor
report
signific
increas
experiment
model
human
endotoxemia
well
circul
patient
infect
suggest
import
role
solubl
tlr
modul
inflamm
infect
potenti
use
test
diagnost
marker
therefor
larger
valid
studi
larger
patient
cohort
warrant
order
abl
draw
definit
conclus
regard
diagnost
use
human
inflammatori
diseas
